posted on 2021-11-08, 18:34authored byJordan E. Krechmer, Brennan Phillips, Nicholas Chaloux, Russell Shomberg, Conner Daube, Gaurav Manchanda, Sam Murray, Alex McCarthy, Rodrigo Fonseca, Jinen Thakkar, Brice Loose, Scott C. Herndon, John T. Jayne, Douglas R. Worsnop, Manjula R. Canagaratna
Medical shortages
during the COVID-19 pandemic saw numerous efforts
to 3D print personal protective equipment and treatment supplies.
There is, however, little research on the potential biocompatibility
of 3D-printed parts using typical polymeric resins as pertaining to
volatile organic compounds (VOCs), which have specific relevance for
respiratory circuit equipment. Here, we measured VOCs emitted from
freshly printed stereolithography (SLA) replacement medical parts
using proton transfer reaction mass spectrometry and infrared differential
absorption spectroscopy, and particulates using a scanning mobility
particle sizer. We observed emission factors for individual VOCs ranging
from ∼0.001 to ∼10 ng cm–3 min–1. Emissions were heavily dependent on postprint curing
and mildly dependent on the type of SLA resin. Curing reduced the
emission of all observed chemicals, and no compounds exceeded the
recommended dose of 360 μg/d. VOC emissions steadily decreased
for all parts over time, with an average e-folding
time scale (time to decrease to 1/e of the starting
value) of 2.6 ± 0.9 h.